Citrine Medicine Co., Ltd – co-founded by Eight Roads, F-Prime Capital and Vivo Capital – on Monday announced the completion of its $80-million Series A round led by next-generation life science-focused Quan Capital, per a company statement.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
